The U.S. House panel that oversees federal drug enforcement is scheduled to vote this week on a bill to dramatically expand opportunities for research on the medical benefits of marijuana. "For many of my Republican colleagues, the most difficult marijuana reform vote to take is the first one. “The Medical Cannabis Research Act would, in theory, dramatically expand access to medical grade cannabis for researchers for scientific purposes,” said NORML Political Director Justin Strekal. And, he blamed the lack of progress in federal marijuana reform since the president took office on his broader feud with Sessions. "In a way, the marijuana reform movement is an inadvertent casualty of the Trump-Sessions eroded relationship."

Source: Forbes September 10, 2018 15:26 UTC